AML is a hematologic cancer that is clinically heterogeneous, with a wide range of clinical outcomes. DNA methylation changes are a hallmark of AML but are not routinely used as a criterion for risk ...

Improved Outcome for Patients With Middle Ear Rhabdomyosarcoma: A Children’s Oncology Group Study PURPOSE: To determine the relationship between multiple genetic features, tumor morphology, and ...

(MENAFN- EIN Presswire) EINPresswire/ -- The global Molecular Cytogenetics Market is witnessing strong and sustained growth as precision diagnostics, oncology research, and genetic disorder screening ...

Neuberg Sehgal Path Lab, a leading name in diagnostic services, has announces the launch of cutting-edge cytogenetics testing technology at its facilities in Mumbai. This advanced diagnostic tool is ...